Where does Roivios Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Roivios Limited ranks #12,199 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Roivios Limited hold?

Roivios Limited holds 25 US utility patents granted between 2022 and 2025, spanning 4 technology areas.

What is Roivios Limited's Innovation Score?

Roivios Limited has an Innovation Score of 53.3 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Roivios Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Roivios Limited.

What does claim depth mean for Roivios Limited's patents?

Roivios Limited's patents average 37.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Roivios Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Roivios Limited

Q: What technology areas does Roivios Limited focus on?

Roivios Limited's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 18 patents, ranking #413 of 3,490 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 4 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Roivios ranks #12,199 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 4 technology areas.

#12,199
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.3/100): 37.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R12199 · Foreign Corporation #12,199 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 25 grants
UPPER-Q #12,199/49,997
PHOTO-FINISH Rieter Ingolstadt
CPC-NARROW A61M · 4 areas
INNOV-PAR 53.3/100
CLAIMS-DENSE 37.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Rieter Ingolstadt GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Roivios’s 53.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (21%) Velocity 20.0 pts (37%) Breadth 7.1 pts (13%) Claim depth 15.0 pts (28%)

Qualcomm Incorporated · highest

85
Bausch & Lomb… · near

53
Roivios · this assignee

53
Socpra Sciences ET… · near

53
TetraMem · near

53
Wabash National · near

53
3D Lighting… · lowest

7

What this shows Roivios's Innovation Score is 53.3/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Roivios?

Each dot is one of Roivios’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Roivios’s own 37.8 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Roivios vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Roivios's grants concentrate

Roivios Limited is a focused PatentsView assignee: 4 CPC subclasses with 72% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (9 grants) versus a trough of 5 in 2023. By volume, Roivios sits between Rieter Ingolstadt GmbH and Salunda Limited.

Roivios's three-year grant acceleration

Roivios Limited shows 21 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rieter Ingolstadt

25
Rinnai America

25
Robotic Research

25
Rocky Research

25
Röhm

25
S P E P Acquisiti…

25
Saga University

25
Salunda

25
Roivios ◀

25

What this shows Roivios holds 25 patents at rank #12,198, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roivios

By rank, the assignees closest to #12,198 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Roivios's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Roivios, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Roivios ranks #413 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Socpra Sciences ET Genie S.E.C. 53 TetraMem Inc. 53 Bausch & Lomb Incorporated 53 Wabash National, L.P. 53

Roivios's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Roivios Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	7	28.0%
2023	5	20.0%
2024	9	36.0%
2025partial year	4	16.0%

Which technologies does Roivios Limited patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 18

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 12

A61B - DIAGNOSIS; SURGERY; Identification 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Roivios Limited's patent record in context - here's where to go next.

Roivios Limited's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 72% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #12,199 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Roivios Limited against Rieter Ingolstadt GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.